Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata5
|
ENSMUSG00000015627.5 | GATA binding protein 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_180341694_180342028 | Gata5 | 7162 | 0.128605 | 0.55 | 5.4e-06 | Click! |
chr2_180339768_180340253 | Gata5 | 5311 | 0.136333 | 0.41 | 1.0e-03 | Click! |
chr2_180353281_180353578 | Gata5 | 18730 | 0.109895 | -0.37 | 3.5e-03 | Click! |
chr2_180342187_180342480 | Gata5 | 7634 | 0.127325 | 0.37 | 3.9e-03 | Click! |
chr2_180341010_180341408 | Gata5 | 6510 | 0.130716 | 0.32 | 1.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_53340367_53340889 | 15.30 |
Pln |
phospholamban |
2923 |
0.17 |
chr1_188006897_188007904 | 14.29 |
9330162B11Rik |
RIKEN cDNA 9330162B11 gene |
1590 |
0.45 |
chr11_22170917_22171472 | 13.57 |
Ehbp1 |
EH domain binding protein 1 |
216 |
0.96 |
chr6_31612888_31614126 | 12.99 |
Gm43154 |
predicted gene 43154 |
8218 |
0.19 |
chr7_81057643_81058977 | 11.36 |
Alpk3 |
alpha-kinase 3 |
710 |
0.41 |
chr8_84701273_84703379 | 11.24 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr14_63231019_63231782 | 10.79 |
Gata4 |
GATA binding protein 4 |
13848 |
0.16 |
chr9_105520039_105521535 | 10.77 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr2_17460205_17460550 | 10.76 |
Nebl |
nebulette |
244 |
0.96 |
chr5_100570574_100571670 | 10.68 |
Plac8 |
placenta-specific 8 |
1070 |
0.43 |
chr2_17459201_17459498 | 10.66 |
Nebl |
nebulette |
1272 |
0.59 |
chr2_160326169_160327486 | 10.19 |
Gm826 |
predicted gene 826 |
667 |
0.78 |
chr4_154926952_154928851 | 10.06 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr3_138001691_138001895 | 9.98 |
Gm19708 |
predicted gene, 19708 |
854 |
0.51 |
chr11_103102696_103105788 | 9.51 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr13_38579867_38580777 | 9.45 |
Gm40922 |
predicted gene, 40922 |
25457 |
0.11 |
chr11_102363631_102364272 | 9.20 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
247 |
0.85 |
chr15_9073302_9073784 | 9.17 |
Nadk2 |
NAD kinase 2, mitochondrial |
1734 |
0.41 |
chr10_93143259_93144113 | 9.14 |
Cdk17 |
cyclin-dependent kinase 17 |
17189 |
0.17 |
chr1_82647929_82648309 | 9.09 |
n-R5s213 |
nuclear encoded rRNA 5S 213 |
13106 |
0.16 |
chr10_60348094_60348748 | 8.91 |
Vsir |
V-set immunoregulatory receptor |
902 |
0.6 |
chr16_38363311_38363597 | 8.82 |
Popdc2 |
popeye domain containing 2 |
1209 |
0.35 |
chr7_81566287_81566808 | 8.75 |
Fsd2 |
fibronectin type III and SPRY domain containing 2 |
397 |
0.74 |
chr3_33834886_33835506 | 8.66 |
Ccdc39 |
coiled-coil domain containing 39 |
8656 |
0.15 |
chr16_85132591_85133705 | 8.59 |
Gm49226 |
predicted gene, 49226 |
15681 |
0.18 |
chr8_80497324_80498362 | 8.53 |
Gypa |
glycophorin A |
4062 |
0.27 |
chr8_61900734_61900909 | 8.50 |
Palld |
palladin, cytoskeletal associated protein |
1848 |
0.32 |
chr15_44457385_44458529 | 8.36 |
Pkhd1l1 |
polycystic kidney and hepatic disease 1-like 1 |
404 |
0.83 |
chrX_7966155_7966575 | 8.28 |
Gata1 |
GATA binding protein 1 |
1545 |
0.2 |
chr6_97929540_97930859 | 8.23 |
Mitf |
melanogenesis associated transcription factor |
400 |
0.89 |
chr1_58970537_58971332 | 8.17 |
Trak2 |
trafficking protein, kinesin binding 2 |
2495 |
0.2 |
chr3_142757733_142758219 | 8.17 |
Gtf2b |
general transcription factor IIB |
7069 |
0.12 |
chr9_85324630_85325846 | 8.14 |
Tent5a |
terminal nucleotidyltransferase 5A |
1886 |
0.28 |
chr6_117888079_117889227 | 8.09 |
Gm29509 |
predicted gene 29509 |
10548 |
0.11 |
chr5_65348144_65349340 | 8.05 |
Klb |
klotho beta |
334 |
0.81 |
chr7_103809605_103809899 | 8.02 |
Hbb-bt |
hemoglobin, beta adult t chain |
4244 |
0.07 |
chr2_172348091_172348896 | 7.99 |
Fam210b |
family with sequence similarity 210, member B |
2928 |
0.18 |
chr11_65266805_65267363 | 7.92 |
Myocd |
myocardin |
2770 |
0.29 |
chr2_163396823_163398215 | 7.91 |
Jph2 |
junctophilin 2 |
430 |
0.77 |
chr2_114049476_114049927 | 7.90 |
Actc1 |
actin, alpha, cardiac muscle 1 |
3186 |
0.2 |
chr8_39010738_39011315 | 7.84 |
Tusc3 |
tumor suppressor candidate 3 |
5116 |
0.27 |
chr16_23610624_23611298 | 7.82 |
Rtp4 |
receptor transporter protein 4 |
1036 |
0.59 |
chr11_78072614_78073453 | 7.77 |
Mir144 |
microRNA 144 |
28 |
0.51 |
chr17_40810971_40811398 | 7.75 |
Rhag |
Rhesus blood group-associated A glycoprotein |
0 |
0.97 |
chr15_41751298_41752572 | 7.68 |
Oxr1 |
oxidation resistance 1 |
234 |
0.95 |
chr10_59403301_59404650 | 7.54 |
Pla2g12b |
phospholipase A2, group XIIB |
315 |
0.88 |
chr11_72406421_72408105 | 7.48 |
Smtnl2 |
smoothelin-like 2 |
4155 |
0.15 |
chr6_87429102_87429741 | 7.48 |
Bmp10 |
bone morphogenetic protein 10 |
427 |
0.79 |
chr9_77341896_77342983 | 7.42 |
Mlip |
muscular LMNA-interacting protein |
1812 |
0.31 |
chr16_73835811_73836328 | 7.37 |
Robo2 |
roundabout guidance receptor 2 |
63816 |
0.14 |
chr16_38371842_38372227 | 7.31 |
Popdc2 |
popeye domain containing 2 |
36 |
0.96 |
chr8_122282630_122283784 | 7.30 |
Zfpm1 |
zinc finger protein, multitype 1 |
1066 |
0.46 |
chr19_56389633_56389987 | 7.23 |
Nrap |
nebulin-related anchoring protein |
67 |
0.97 |
chr18_11047852_11049020 | 7.22 |
Gata6os |
GATA binding protein 6, opposite strand |
799 |
0.66 |
chr9_92276388_92276986 | 7.21 |
Plscr2 |
phospholipid scramblase 2 |
941 |
0.48 |
chr2_28620746_28622145 | 7.20 |
Gfi1b |
growth factor independent 1B |
500 |
0.68 |
chr18_50028322_50029158 | 7.19 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
2278 |
0.32 |
chr8_67948178_67948899 | 7.16 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
3341 |
0.28 |
chr12_117657998_117660727 | 7.14 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr2_77765256_77765698 | 7.13 |
Zfp385b |
zinc finger protein 385B |
45738 |
0.16 |
chr10_116177098_116178206 | 7.13 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
241 |
0.95 |
chr10_63458795_63458946 | 7.12 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
1360 |
0.42 |
chrX_136144132_136144311 | 7.11 |
Bex4 |
brain expressed X-linked 4 |
5225 |
0.13 |
chr10_93454496_93455097 | 7.09 |
Lta4h |
leukotriene A4 hydrolase |
1345 |
0.38 |
chr6_122393478_122393837 | 7.09 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
2278 |
0.21 |
chr3_152264546_152264733 | 7.05 |
Nexn |
nexilin |
1128 |
0.39 |
chr9_14717947_14718502 | 7.03 |
Piwil4 |
piwi-like RNA-mediated gene silencing 4 |
249 |
0.84 |
chr10_62332356_62333129 | 7.03 |
Hk1 |
hexokinase 1 |
4975 |
0.18 |
chr6_139586816_139587911 | 6.98 |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma |
126 |
0.96 |
chr5_83354729_83355431 | 6.95 |
Tecrl |
trans-2,3-enoyl-CoA reductase-like |
115 |
0.98 |
chr8_33926179_33926910 | 6.91 |
Rbpms |
RNA binding protein gene with multiple splicing |
2732 |
0.25 |
chr5_113972560_113973340 | 6.91 |
Ssh1 |
slingshot protein phosphatase 1 |
6194 |
0.14 |
chr2_156778021_156779417 | 6.89 |
Myl9 |
myosin, light polypeptide 9, regulatory |
202 |
0.9 |
chr10_99284362_99285186 | 6.86 |
Gm48089 |
predicted gene, 48089 |
9978 |
0.12 |
chr13_32234216_32234651 | 6.84 |
Gmds |
GDP-mannose 4, 6-dehydratase |
7192 |
0.28 |
chr9_101198368_101199080 | 6.84 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
127 |
0.94 |
chr14_63067248_63068361 | 6.82 |
Defb42 |
defensin beta 42 |
12731 |
0.11 |
chr18_11058575_11059292 | 6.81 |
Gata6 |
GATA binding protein 6 |
114 |
0.97 |
chr12_36436829_36437360 | 6.81 |
D630036H23Rik |
RIKEN cDNA D630036H23 gene |
54913 |
0.11 |
chr18_10920545_10921042 | 6.76 |
Gm7575 |
predicted gene 7575 |
8091 |
0.22 |
chr19_36118883_36119585 | 6.76 |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
676 |
0.71 |
chr2_19690013_19690679 | 6.72 |
Gm24670 |
predicted gene, 24670 |
942 |
0.47 |
chr10_58394969_58395625 | 6.72 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
909 |
0.6 |
chr3_127893429_127894301 | 6.70 |
Fam241a |
family with sequence similarity 241, member A |
2423 |
0.2 |
chr18_62174392_62175675 | 6.67 |
Adrb2 |
adrenergic receptor, beta 2 |
4926 |
0.21 |
chr11_86742805_86743091 | 6.64 |
Cltc |
clathrin, heavy polypeptide (Hc) |
14553 |
0.18 |
chr5_137570868_137571950 | 6.59 |
Tfr2 |
transferrin receptor 2 |
42 |
0.93 |
chrX_38575712_38576177 | 6.57 |
Cul4b |
cullin 4B |
239 |
0.93 |
chr13_95671197_95671708 | 6.56 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
67 |
0.96 |
chr6_55336550_55338274 | 6.53 |
Aqp1 |
aquaporin 1 |
980 |
0.5 |
chr17_9977578_9977801 | 6.49 |
Gm49809 |
predicted gene, 49809 |
29852 |
0.19 |
chr13_52046093_52046875 | 6.47 |
Gm37872 |
predicted gene, 37872 |
24557 |
0.18 |
chr4_154023853_154024071 | 6.46 |
Smim1 |
small integral membrane protein 1 |
361 |
0.76 |
chr6_137931136_137931732 | 6.42 |
Gm24308 |
predicted gene, 24308 |
11463 |
0.27 |
chr3_144759885_144761021 | 6.40 |
Clca3a1 |
chloride channel accessory 3A1 |
388 |
0.78 |
chr17_86185508_86186123 | 6.37 |
AC154542.1 |
TEC |
10240 |
0.2 |
chr8_94985246_94986199 | 6.33 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
154 |
0.93 |
chr11_84822134_84823653 | 6.33 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
3378 |
0.15 |
chr2_26012995_26013283 | 6.29 |
Ubac1 |
ubiquitin associated domain containing 1 |
2186 |
0.22 |
chr1_51288641_51290950 | 6.27 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr11_109587022_109588156 | 6.26 |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
23843 |
0.13 |
chr7_143005720_143007083 | 6.26 |
Tspan32 |
tetraspanin 32 |
473 |
0.68 |
chr6_53986510_53986917 | 6.25 |
4921529L05Rik |
RIKEN cDNA 4921529L05 gene |
7984 |
0.2 |
chr2_32127772_32128677 | 6.25 |
Prrc2b |
proline-rich coiled-coil 2B |
22858 |
0.1 |
chr18_35094069_35094758 | 6.25 |
Gm3587 |
predicted gene 3587 |
6790 |
0.2 |
chr16_90738322_90739000 | 6.25 |
Mrap |
melanocortin 2 receptor accessory protein |
337 |
0.85 |
chr11_54026747_54027441 | 6.23 |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
858 |
0.54 |
chr15_9074646_9075526 | 6.22 |
Nadk2 |
NAD kinase 2, mitochondrial |
191 |
0.96 |
chr10_98624508_98624896 | 6.21 |
Gm5427 |
predicted gene 5427 |
75008 |
0.11 |
chr8_13202537_13203450 | 6.18 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
2173 |
0.16 |
chr5_75975825_75977229 | 6.13 |
Kdr |
kinase insert domain protein receptor |
1931 |
0.31 |
chr11_58641514_58641665 | 6.11 |
Trim58 |
tripartite motif-containing 58 |
1124 |
0.26 |
chr11_90726819_90728183 | 6.05 |
Tom1l1 |
target of myb1-like 1 (chicken) |
39135 |
0.15 |
chr11_86586191_86587628 | 6.03 |
Vmp1 |
vacuole membrane protein 1 |
28 |
0.97 |
chr4_147986271_147987020 | 6.02 |
Nppb |
natriuretic peptide type B |
857 |
0.42 |
chr3_127894696_127895269 | 5.99 |
Fam241a |
family with sequence similarity 241, member A |
1306 |
0.34 |
chr14_70775836_70776463 | 5.96 |
Dok2 |
docking protein 2 |
29 |
0.98 |
chr6_56917734_56918454 | 5.95 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
5630 |
0.13 |
chr15_76666348_76670076 | 5.93 |
Foxh1 |
forkhead box H1 |
1590 |
0.15 |
chr15_66559688_66560010 | 5.92 |
Tmem71 |
transmembrane protein 71 |
1254 |
0.49 |
chr2_91949326_91950727 | 5.91 |
Dgkz |
diacylglycerol kinase zeta |
285 |
0.84 |
chr11_61075424_61076210 | 5.91 |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
10013 |
0.17 |
chr4_46040285_46040964 | 5.88 |
Tmod1 |
tropomodulin 1 |
1415 |
0.43 |
chr12_32123180_32123577 | 5.87 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
324 |
0.89 |
chr3_103132589_103132769 | 5.86 |
Dennd2c |
DENN/MADD domain containing 2C |
5123 |
0.14 |
chr11_37554053_37554216 | 5.85 |
Gm12128 |
predicted gene 12128 |
104855 |
0.08 |
chr5_115018013_115018676 | 5.84 |
Sppl3 |
signal peptide peptidase 3 |
6847 |
0.1 |
chr9_116872888_116873412 | 5.83 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
50331 |
0.18 |
chr3_101551232_101552184 | 5.81 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
25852 |
0.16 |
chr11_66912020_66913244 | 5.80 |
Pirt |
phosphoinositide-interacting regulator of transient receptor potential channels |
651 |
0.72 |
chr4_43558006_43559275 | 5.79 |
Tln1 |
talin 1 |
180 |
0.86 |
chr10_58372452_58372991 | 5.78 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
1267 |
0.46 |
chr11_11836398_11837549 | 5.77 |
Ddc |
dopa decarboxylase |
693 |
0.68 |
chr9_24766430_24766801 | 5.77 |
Tbx20 |
T-box 20 |
3065 |
0.25 |
chr4_135727528_135728972 | 5.77 |
Il22ra1 |
interleukin 22 receptor, alpha 1 |
78 |
0.96 |
chr19_17354797_17355050 | 5.76 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
1744 |
0.41 |
chr9_24768577_24769049 | 5.72 |
Tbx20 |
T-box 20 |
867 |
0.6 |
chr1_33945162_33945435 | 5.71 |
Gm28631 |
predicted gene 28631 |
18387 |
0.12 |
chr5_105138680_105139011 | 5.70 |
Gbp9 |
guanylate-binding protein 9 |
694 |
0.3 |
chr9_24769617_24771807 | 5.68 |
Tbx20 |
T-box 20 |
962 |
0.56 |
chrX_7968242_7968552 | 5.66 |
Gata1 |
GATA binding protein 1 |
487 |
0.61 |
chr6_70752264_70752662 | 5.65 |
Rpia |
ribose 5-phosphate isomerase A |
21229 |
0.12 |
chr6_90623236_90623734 | 5.65 |
Slc41a3 |
solute carrier family 41, member 3 |
4338 |
0.16 |
chr10_89423090_89423357 | 5.64 |
Gas2l3 |
growth arrest-specific 2 like 3 |
10619 |
0.25 |
chr16_96200054_96201298 | 5.64 |
Sh3bgr |
SH3-binding domain glutamic acid-rich protein |
5 |
0.97 |
chr11_95341129_95341703 | 5.63 |
Fam117a |
family with sequence similarity 117, member A |
1454 |
0.28 |
chrX_139611787_139611938 | 5.63 |
Rnf128 |
ring finger protein 128 |
495 |
0.83 |
chr3_97076352_97076977 | 5.60 |
4930573H18Rik |
RIKEN cDNA 4930573H18 gene |
16121 |
0.15 |
chr1_133799053_133799204 | 5.59 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
1908 |
0.26 |
chr1_125678382_125678847 | 5.59 |
Gpr39 |
G protein-coupled receptor 39 |
1619 |
0.44 |
chr3_89731508_89731661 | 5.59 |
Adar |
adenosine deaminase, RNA-specific |
836 |
0.52 |
chr10_40164584_40165218 | 5.57 |
Gm31992 |
predicted gene, 31992 |
791 |
0.53 |
chr10_108595779_108596540 | 5.56 |
Syt1 |
synaptotagmin I |
40805 |
0.18 |
chr6_99172721_99173535 | 5.55 |
Foxp1 |
forkhead box P1 |
10110 |
0.29 |
chr18_32541838_32542466 | 5.55 |
Gypc |
glycophorin C |
6734 |
0.21 |
chr7_142474634_142476734 | 5.54 |
Lsp1 |
lymphocyte specific 1 |
690 |
0.52 |
chr8_84901875_84902316 | 5.53 |
Klf1 |
Kruppel-like factor 1 (erythroid) |
167 |
0.86 |
chr17_47174837_47175202 | 5.53 |
Trerf1 |
transcriptional regulating factor 1 |
33803 |
0.17 |
chr14_51130108_51130570 | 5.53 |
Rnase6 |
ribonuclease, RNase A family, 6 |
1258 |
0.24 |
chr4_62515406_62516411 | 5.51 |
Alad |
aminolevulinate, delta-, dehydratase |
3973 |
0.13 |
chr3_135826999_135827214 | 5.49 |
Slc39a8 |
solute carrier family 39 (metal ion transporter), member 8 |
1016 |
0.49 |
chr7_135721379_135721773 | 5.48 |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
5215 |
0.18 |
chr10_68158679_68159064 | 5.47 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
22245 |
0.23 |
chr9_94295166_94295748 | 5.47 |
Gm24200 |
predicted gene, 24200 |
10961 |
0.28 |
chr7_120879515_120880256 | 5.46 |
Eef2k |
eukaryotic elongation factor-2 kinase |
3665 |
0.15 |
chr14_21078036_21078470 | 5.45 |
Adk |
adenosine kinase |
2101 |
0.35 |
chr19_32638036_32638187 | 5.43 |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
18106 |
0.21 |
chr15_82341612_82342178 | 5.42 |
Pheta2 |
PH domain containing endocytic trafficking adaptor 2 |
716 |
0.26 |
chr6_94729909_94730132 | 5.39 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
29862 |
0.17 |
chr10_70120556_70121768 | 5.38 |
Ccdc6 |
coiled-coil domain containing 6 |
24041 |
0.22 |
chr19_25381686_25382798 | 5.37 |
Kank1 |
KN motif and ankyrin repeat domains 1 |
13061 |
0.21 |
chr5_73190710_73191316 | 5.37 |
Gm42571 |
predicted gene 42571 |
596 |
0.5 |
chr2_91119045_91119896 | 5.37 |
Mybpc3 |
myosin binding protein C, cardiac |
1326 |
0.3 |
chr17_48431455_48432112 | 5.36 |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
835 |
0.47 |
chr14_105802599_105803428 | 5.35 |
Gm22406 |
predicted gene, 22406 |
13895 |
0.22 |
chr13_76014527_76014860 | 5.34 |
Rfesd |
Rieske (Fe-S) domain containing |
3775 |
0.15 |
chr10_53342534_53342748 | 5.34 |
Gm47644 |
predicted gene, 47644 |
1593 |
0.27 |
chr8_33884869_33886307 | 5.34 |
Gm26978 |
predicted gene, 26978 |
159 |
0.95 |
chr11_22376584_22377158 | 5.33 |
Rpsa-ps3 |
ribosomal protein SA, pseudogene 3 |
9421 |
0.22 |
chr1_66987630_66987944 | 5.33 |
Lancl1 |
LanC (bacterial lantibiotic synthetase component C)-like 1 |
33278 |
0.12 |
chr16_44765772_44766414 | 5.33 |
Cd200r1 |
CD200 receptor 1 |
267 |
0.88 |
chr19_40812757_40814183 | 5.32 |
Ccnj |
cyclin J |
17809 |
0.16 |
chr18_79257057_79258150 | 5.32 |
Gm2116 |
predicted gene 2116 |
47559 |
0.15 |
chr14_31208319_31209141 | 5.32 |
Tnnc1 |
troponin C, cardiac/slow skeletal |
398 |
0.71 |
chr3_128990459_128991248 | 5.32 |
Gm9387 |
predicted pseudogene 9387 |
35755 |
0.19 |
chr17_62748947_62749663 | 5.31 |
Efna5 |
ephrin A5 |
131839 |
0.06 |
chr3_115819513_115820569 | 5.30 |
Dph5 |
diphthamide biosynthesis 5 |
67796 |
0.08 |
chr10_40737288_40738233 | 5.27 |
Mettl24 |
methyltransferase like 24 |
54478 |
0.13 |
chr4_134315034_134315974 | 5.26 |
Trim63 |
tripartite motif-containing 63 |
292 |
0.83 |
chr2_80037645_80038971 | 5.25 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
721 |
0.79 |
chr17_48271857_48272276 | 5.25 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
373 |
0.79 |
chr4_62515031_62515361 | 5.24 |
Alad |
aminolevulinate, delta-, dehydratase |
4685 |
0.12 |
chr8_123978308_123979538 | 5.21 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4199 |
0.12 |
chr13_8784680_8784957 | 5.21 |
Gm48327 |
predicted gene, 48327 |
13584 |
0.15 |
chr5_107874374_107875235 | 5.20 |
Evi5 |
ecotropic viral integration site 5 |
240 |
0.86 |
chr2_84938833_84938984 | 5.18 |
Slc43a3 |
solute carrier family 43, member 3 |
2018 |
0.22 |
chr11_65649711_65650176 | 5.16 |
Gm26128 |
predicted gene, 26128 |
23549 |
0.21 |
chr8_46246224_46246706 | 5.16 |
Gm10313 |
predicted pseudogene 10313 |
9213 |
0.1 |
chrX_85616079_85616575 | 5.15 |
Gm44378 |
predicted gene, 44378 |
27350 |
0.18 |
chr9_21221233_21221501 | 5.14 |
Gm16754 |
predicted gene, 16754 |
4004 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 33.4 | GO:0003175 | tricuspid valve development(GO:0003175) |
4.6 | 13.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
4.0 | 11.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.6 | 10.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.6 | 10.7 | GO:0002086 | diaphragm contraction(GO:0002086) |
3.1 | 9.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.9 | 8.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.8 | 8.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.7 | 13.7 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
2.7 | 8.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.5 | 7.5 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
2.4 | 7.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
2.3 | 6.8 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
2.1 | 6.4 | GO:0007525 | somatic muscle development(GO:0007525) |
2.1 | 10.3 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
2.0 | 12.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
2.0 | 4.0 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
2.0 | 6.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.0 | 6.0 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
2.0 | 3.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
2.0 | 15.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.9 | 1.9 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.8 | 5.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.8 | 7.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.8 | 5.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.8 | 8.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.7 | 10.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.7 | 5.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.6 | 4.9 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.6 | 6.5 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
1.6 | 1.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.6 | 16.2 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.6 | 4.9 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.6 | 1.6 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.6 | 3.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.6 | 6.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.6 | 4.7 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
1.5 | 4.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.5 | 4.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.5 | 3.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.5 | 4.4 | GO:0002432 | granuloma formation(GO:0002432) |
1.4 | 4.3 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
1.4 | 5.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.4 | 4.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.3 | 6.7 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.3 | 4.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.3 | 11.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.3 | 2.6 | GO:0002576 | platelet degranulation(GO:0002576) |
1.3 | 3.9 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.3 | 7.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.3 | 2.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.3 | 8.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.2 | 3.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.2 | 1.2 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
1.2 | 4.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.2 | 4.6 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.2 | 6.9 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.1 | 4.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.1 | 3.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.1 | 10.3 | GO:0070269 | pyroptosis(GO:0070269) |
1.1 | 3.4 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.1 | 3.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.1 | 1.1 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
1.1 | 3.4 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.1 | 5.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.1 | 3.3 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.1 | 2.2 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.1 | 1.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.1 | 7.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.1 | 6.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.1 | 1.1 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.1 | 2.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.0 | 4.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.0 | 2.1 | GO:0051665 | membrane raft localization(GO:0051665) |
1.0 | 2.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.0 | 3.1 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
1.0 | 6.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.0 | 3.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.0 | 3.0 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
1.0 | 2.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
1.0 | 5.0 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.0 | 4.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.0 | 23.5 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.0 | 2.9 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
1.0 | 3.9 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.0 | 4.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.0 | 1.9 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.0 | 2.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.9 | 3.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.9 | 1.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.9 | 1.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.9 | 2.8 | GO:0042117 | monocyte activation(GO:0042117) |
0.9 | 1.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.9 | 4.6 | GO:0007567 | parturition(GO:0007567) |
0.9 | 4.6 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.9 | 7.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.9 | 2.7 | GO:0032264 | IMP salvage(GO:0032264) |
0.9 | 2.7 | GO:1903416 | response to glycoside(GO:1903416) |
0.9 | 2.7 | GO:0035483 | gastric emptying(GO:0035483) |
0.9 | 3.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.9 | 5.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.9 | 3.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.9 | 1.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.9 | 3.5 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.9 | 1.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.9 | 2.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.9 | 7.9 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.9 | 4.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.9 | 3.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.9 | 1.7 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.9 | 0.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.9 | 7.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.9 | 2.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.9 | 0.9 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.8 | 2.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.8 | 2.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.8 | 2.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.8 | 2.5 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.8 | 1.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.8 | 2.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.8 | 8.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.8 | 1.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.8 | 1.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.8 | 1.7 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.8 | 0.8 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.8 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.8 | 3.3 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.8 | 2.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.8 | 2.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.8 | 4.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.8 | 0.8 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.8 | 10.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.8 | 3.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.8 | 1.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.8 | 2.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.8 | 3.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.8 | 1.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.8 | 4.6 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.8 | 4.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.8 | 2.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.7 | 6.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.7 | 6.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 3.7 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.7 | 5.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.7 | 2.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.7 | 5.9 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.7 | 3.7 | GO:0015879 | carnitine transport(GO:0015879) |
0.7 | 2.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.7 | 2.9 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.7 | 2.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.7 | 4.3 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.7 | 11.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.7 | 5.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.7 | 6.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.7 | 2.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.7 | 2.1 | GO:0036394 | amylase secretion(GO:0036394) |
0.7 | 2.8 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.7 | 3.5 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.7 | 4.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.7 | 0.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.7 | 4.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.7 | 10.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.7 | 2.0 | GO:0032439 | endosome localization(GO:0032439) |
0.7 | 1.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.7 | 5.4 | GO:0048821 | erythrocyte development(GO:0048821) |
0.7 | 2.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.7 | 6.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.7 | 2.0 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.7 | 3.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.7 | 1.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.7 | 1.3 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.7 | 4.6 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.6 | 1.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.6 | 2.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 2.6 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.6 | 8.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.6 | 1.9 | GO:0035973 | aggrephagy(GO:0035973) |
0.6 | 3.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.6 | 1.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.6 | 2.6 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.6 | 5.7 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.6 | 3.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 1.9 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.6 | 0.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.6 | 9.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.6 | 1.9 | GO:0061010 | gall bladder development(GO:0061010) |
0.6 | 0.6 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.6 | 1.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.6 | 1.8 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.6 | 3.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 7.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.6 | 3.6 | GO:0060613 | fat pad development(GO:0060613) |
0.6 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.6 | 3.0 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.6 | 4.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.6 | 1.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 2.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.6 | 0.6 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.6 | 1.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.6 | 2.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 2.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.6 | 1.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.6 | 1.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.6 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.6 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.6 | 2.3 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.6 | 1.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.6 | 1.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.6 | 1.7 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.6 | 3.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.6 | 0.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.5 | 7.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.5 | 1.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.5 | 6.0 | GO:0034340 | response to type I interferon(GO:0034340) |
0.5 | 0.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.5 | 2.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.5 | 3.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 0.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.5 | 5.3 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.5 | 1.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 1.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.5 | 0.5 | GO:0008050 | female courtship behavior(GO:0008050) |
0.5 | 2.1 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.5 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 1.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.5 | 1.6 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.5 | 2.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 1.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 1.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 2.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 4.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 1.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.5 | 1.5 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.5 | 1.5 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 4.5 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.5 | 2.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.5 | 5.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 6.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.5 | 2.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 4.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.5 | 1.5 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.5 | 1.0 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.5 | 1.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.5 | 8.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 2.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 3.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.5 | 1.5 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.5 | 1.9 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.5 | 1.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.5 | 1.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.5 | 1.4 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.5 | 1.0 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.5 | 3.3 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.5 | 1.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.5 | 1.4 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.5 | 0.5 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.5 | 1.9 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.5 | 0.5 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.5 | 2.8 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.5 | 1.4 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.5 | 2.8 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 2.8 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.5 | 1.4 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.5 | 9.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.5 | 1.4 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.5 | 0.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 1.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.5 | 9.6 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.5 | 0.9 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.4 | 0.9 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 4.5 | GO:0043302 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.4 | 3.6 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 0.9 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 1.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.4 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 0.9 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.4 | 0.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.4 | 6.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 1.3 | GO:0015677 | copper ion import(GO:0015677) |
0.4 | 1.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.4 | 2.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.4 | 3.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.4 | 1.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 1.3 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 11.1 | GO:0030239 | myofibril assembly(GO:0030239) |
0.4 | 2.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 15.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.4 | 0.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.4 | 3.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 1.7 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.4 | 1.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 1.2 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 1.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 7.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 1.6 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.4 | 0.8 | GO:0002215 | defense response to nematode(GO:0002215) |
0.4 | 1.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 0.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 3.2 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.4 | 0.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.4 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.4 | 2.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.4 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 0.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.4 | 0.4 | GO:0050904 | diapedesis(GO:0050904) |
0.4 | 1.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.4 | 5.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.4 | 0.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.4 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 5.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 5.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 0.8 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.4 | 1.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 1.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 1.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.4 | 1.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.4 | 0.8 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.4 | 2.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 1.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.4 | 1.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.4 | 4.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.4 | 0.4 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.4 | 5.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 2.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.4 | 0.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 1.1 | GO:0006848 | pyruvate transport(GO:0006848) |
0.4 | 0.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.4 | 1.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.4 | 1.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 1.5 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 0.4 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.4 | 1.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 0.7 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.4 | 0.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.4 | 2.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 1.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.4 | 0.4 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 3.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 2.9 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.4 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 0.4 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.4 | 1.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.4 | 0.4 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 0.7 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 0.7 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 1.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 1.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 1.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.4 | 0.7 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 2.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 1.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 1.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.3 | 3.1 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 1.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 1.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 1.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 2.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 2.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 0.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 0.7 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.3 | 2.0 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 1.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.0 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 4.6 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 1.7 | GO:0071800 | podosome assembly(GO:0071800) |
0.3 | 1.0 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 2.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 1.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 2.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 4.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 2.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 0.7 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.3 | 5.2 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.3 | 1.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 0.6 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 1.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 2.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 1.0 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 1.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.3 | 1.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 0.6 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.3 | 6.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 0.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 0.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.3 | 8.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 1.6 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.3 | 1.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 3.4 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 1.2 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.3 | 0.9 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 1.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.3 | 1.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 1.2 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.3 | 5.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 1.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.3 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.3 | 2.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 0.6 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 0.9 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 0.6 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.3 | 1.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 0.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 2.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 1.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 0.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 0.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.3 | 1.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 1.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 1.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.3 | 1.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 0.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 2.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.3 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 6.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 0.9 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.3 | 1.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.9 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.6 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.3 | 0.6 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 0.6 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.3 | 1.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.3 | 2.0 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.3 | 1.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.3 | 0.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.3 | 1.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 0.6 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 1.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 1.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 1.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 1.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.6 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.3 | 0.6 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.3 | 0.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 2.5 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.3 | 0.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 1.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 2.7 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 0.3 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.3 | 0.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 0.8 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 2.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 2.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 0.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 0.5 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 0.5 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 0.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.3 | 0.5 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 1.3 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 2.1 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.3 | 4.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 1.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 1.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 0.5 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.3 | 1.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.8 | GO:0032347 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) regulation of aldosterone biosynthetic process(GO:0032347) |
0.3 | 3.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.3 | 0.5 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.3 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 1.3 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.3 | 0.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 3.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.3 | 0.8 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 0.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 2.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 1.8 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.3 | 0.5 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.3 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 1.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.3 | 0.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 0.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 0.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 0.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 0.8 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.3 | 0.8 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.2 | 2.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 2.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 1.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 1.7 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 0.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 1.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 1.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.2 | 5.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 1.2 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.2 | 4.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 0.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 0.2 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.5 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.2 | 0.9 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 1.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 0.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.5 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.2 | 0.9 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.2 | 3.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 1.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.2 | 0.7 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.2 | 0.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 4.4 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 1.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 0.5 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.2 | 2.1 | GO:0019400 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.2 | 0.9 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.4 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.2 | 3.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 1.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.7 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.4 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.2 | 0.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 1.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 4.0 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.7 | GO:0038001 | paracrine signaling(GO:0038001) |
0.2 | 2.6 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.2 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.2 | 0.2 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.2 | 0.6 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 0.2 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 2.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 1.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 1.1 | GO:0072413 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.2 | 1.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 1.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.2 | 1.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.6 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 2.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.8 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.2 | 0.4 | GO:0071459 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.2 | 0.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.6 | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
0.2 | 0.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 0.4 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 1.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 0.6 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.2 | 0.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.4 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 1.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.4 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 0.2 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.2 | 0.6 | GO:0033387 | putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 0.6 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 2.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 1.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 1.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 1.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 1.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 1.6 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 1.0 | GO:0042168 | heme metabolic process(GO:0042168) |
0.2 | 0.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 0.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.2 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.2 | 0.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.6 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.2 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 3.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 0.6 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.7 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.2 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.4 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.2 | 0.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.2 | 0.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 1.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 2.4 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.2 | 0.9 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.7 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.2 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 1.8 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 1.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.2 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.2 | 0.7 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.2 | 3.0 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.2 | 0.5 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 2.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 1.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 1.2 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.2 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 1.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 0.2 | GO:0002579 | regulation of antigen processing and presentation(GO:0002577) positive regulation of antigen processing and presentation(GO:0002579) |
0.2 | 0.3 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.2 | 0.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.2 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 8.7 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.9 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 0.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 0.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 2.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 1.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 1.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.6 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 1.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 1.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 1.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.6 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 5.9 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 0.9 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 4.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 1.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 3.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.2 | 0.5 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.2 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 0.9 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.2 | 0.9 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 1.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 1.6 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.2 | 0.3 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.5 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.2 | 0.5 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.2 | 1.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.2 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 1.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.6 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.2 | 0.2 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.2 | 0.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 0.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.4 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.4 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 3.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 2.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.9 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.3 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 1.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.7 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.4 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.3 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.1 | 1.0 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.3 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 3.0 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.3 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 1.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 1.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 8.3 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.4 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.4 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 1.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 1.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.1 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 0.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 4.5 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 1.2 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.9 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 1.7 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.4 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 1.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.8 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.3 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.6 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 1.2 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 1.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 1.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.5 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 3.7 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.1 | 0.7 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 2.5 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.2 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.8 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.7 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.2 | GO:1990748 | cellular detoxification(GO:1990748) |
0.1 | 0.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.5 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 2.7 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.1 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) primary lung bud formation(GO:0060431) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.3 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.1 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.1 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.3 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.9 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 1.3 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.8 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 1.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 3.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.5 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.5 | GO:0042559 | tetrahydrobiopterin biosynthetic process(GO:0006729) pteridine-containing compound biosynthetic process(GO:0042559) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.3 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 0.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.5 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.1 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.6 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.3 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.6 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.2 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.4 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 0.5 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 1.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 1.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 1.2 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.7 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.1 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.5 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 1.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) |
0.1 | 0.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.1 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.5 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.2 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 1.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 1.3 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.3 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 1.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.1 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 1.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.1 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.2 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 1.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.1 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.1 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.4 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 1.6 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 2.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.1 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 0.3 | GO:0046641 | regulation of alpha-beta T cell proliferation(GO:0046640) positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.5 | GO:0090169 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.1 | 0.1 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.1 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 0.3 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.3 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.2 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) |
0.1 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 1.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 1.6 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.1 | 0.1 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.8 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.8 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 1.0 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
0.1 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 0.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.1 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.4 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.5 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.6 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.9 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) insulin processing(GO:0030070) |
0.1 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.2 | GO:0046794 | transport of virus(GO:0046794) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 1.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.0 | 0.0 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 1.6 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.1 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.0 | 0.2 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:1990266 | neutrophil migration(GO:1990266) |
0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 1.8 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.3 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.0 | 1.0 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.2 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.0 | 0.0 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.0 | 0.3 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 1.0 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.2 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.0 | 0.0 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.5 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.2 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 1.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.0 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.0 | 0.2 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.2 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.1 | GO:0051194 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.0 | 1.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.0 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.0 | 0.1 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 3.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.0 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.0 | 0.0 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.0 | 0.0 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.0 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.0 | 0.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.1 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.8 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 2.9 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 | 0.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.1 | GO:0035930 | corticosteroid hormone secretion(GO:0035930) glucocorticoid secretion(GO:0035933) regulation of corticosteroid hormone secretion(GO:2000846) regulation of glucocorticoid secretion(GO:2000849) |
0.0 | 0.9 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.1 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.0 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.0 | 0.0 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.1 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.0 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.0 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.0 | 0.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.0 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.0 | 0.1 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.0 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.0 | 0.0 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.0 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.0 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.3 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.2 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.0 | 0.0 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) negative regulation of melanin biosynthetic process(GO:0048022) regulation of secondary metabolite biosynthetic process(GO:1900376) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 1.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.4 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.0 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.0 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.0 | 0.2 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.0 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 0.0 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.4 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.0 | 0.0 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.0 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.0 | 0.0 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 21.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
3.0 | 8.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.3 | 11.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.0 | 9.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.9 | 14.8 | GO:0005861 | troponin complex(GO:0005861) |
1.8 | 8.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.6 | 9.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.4 | 11.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.4 | 5.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.4 | 4.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.3 | 4.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.3 | 7.7 | GO:0042629 | mast cell granule(GO:0042629) |
1.2 | 17.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.2 | 4.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.1 | 5.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.0 | 4.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.0 | 7.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.0 | 5.0 | GO:0071547 | piP-body(GO:0071547) |
1.0 | 3.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.0 | 2.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 2.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.9 | 4.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 7.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 3.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 12.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.8 | 3.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.8 | 2.3 | GO:0031523 | Myb complex(GO:0031523) |
0.7 | 4.4 | GO:1990462 | omegasome(GO:1990462) |
0.7 | 2.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.7 | 2.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.7 | 2.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.7 | 4.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 0.7 | GO:0001939 | female pronucleus(GO:0001939) |
0.7 | 19.4 | GO:0031672 | A band(GO:0031672) |
0.7 | 2.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 0.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.7 | 3.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.6 | 9.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.6 | 2.5 | GO:0045180 | basal cortex(GO:0045180) |
0.6 | 47.9 | GO:0031674 | I band(GO:0031674) |
0.6 | 6.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.6 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.6 | 24.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.6 | 2.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.6 | 3.9 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.5 | 5.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 5.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 1.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.5 | 3.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 1.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.5 | 3.1 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 5.1 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.5 | 7.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.5 | 3.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 1.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 9.6 | GO:0014704 | intercalated disc(GO:0014704) |
0.5 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 1.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 1.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 2.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 1.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 2.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 2.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 2.1 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 1.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 2.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 2.0 | GO:0042641 | actomyosin(GO:0042641) |
0.4 | 4.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.4 | 4.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 4.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 1.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 1.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 2.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 0.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 1.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 1.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 1.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 5.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 3.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 2.9 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 1.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 3.7 | GO:0002102 | podosome(GO:0002102) |
0.3 | 1.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 1.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.3 | 1.2 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 0.6 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 0.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 5.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 1.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 3.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 12.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 2.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 2.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 27.3 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 21.8 | GO:0042383 | sarcolemma(GO:0042383) |
0.3 | 2.2 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 2.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 1.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 1.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 4.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 1.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 4.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 1.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 2.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 1.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 0.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.5 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 0.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 4.5 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 1.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 1.2 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 1.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 57.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 3.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 1.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.2 | GO:0044440 | endosomal part(GO:0044440) |
0.2 | 0.9 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 1.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.9 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.6 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.2 | 2.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 1.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 1.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.2 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 13.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 5.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 0.8 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 1.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 1.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 3.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 1.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 2.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.3 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 4.9 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 2.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.2 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.5 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 0.8 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 0.8 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 0.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 0.5 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 3.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 1.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 9.4 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 1.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 5.1 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 4.5 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 0.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 4.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 1.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 14.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 2.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 3.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 8.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 1.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.9 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 8.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 2.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 3.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 9.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.9 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.6 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 1.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 3.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.8 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 2.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 13.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.1 | 1.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 1.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 4.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 4.3 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 1.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 2.4 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 3.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 6.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 1.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 1.3 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 1.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.9 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 2.2 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 3.9 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 1.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 5.0 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 12.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 3.4 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 8.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 1.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 1.0 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 1.0 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 34.8 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 8.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 4.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 4.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.5 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.2 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 2.4 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.0 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.0 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.1 | GO:0005776 | autophagosome(GO:0005776) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 15.0 | GO:0031433 | telethonin binding(GO:0031433) |
2.9 | 11.8 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.6 | 12.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.4 | 7.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
2.4 | 9.5 | GO:0031014 | troponin T binding(GO:0031014) |
2.2 | 6.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
2.0 | 6.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.9 | 5.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.8 | 12.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.7 | 5.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.7 | 3.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.7 | 8.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.7 | 5.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.7 | 6.6 | GO:0034584 | piRNA binding(GO:0034584) |
1.6 | 6.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.5 | 9.1 | GO:0034809 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
1.5 | 11.9 | GO:0031432 | titin binding(GO:0031432) |
1.4 | 29.0 | GO:0030506 | ankyrin binding(GO:0030506) |
1.4 | 1.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.4 | 9.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.4 | 5.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.3 | 9.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
1.3 | 11.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.3 | 5.2 | GO:0043515 | kinetochore binding(GO:0043515) |
1.3 | 5.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.3 | 3.9 | GO:0051379 | epinephrine binding(GO:0051379) |
1.3 | 5.1 | GO:0015265 | urea channel activity(GO:0015265) |
1.3 | 5.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.2 | 3.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.2 | 9.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.2 | 2.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.1 | 3.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.1 | 6.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.1 | 4.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 2.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.1 | 6.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.1 | 3.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.1 | 4.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.1 | 5.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.0 | 9.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.0 | 2.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.0 | 4.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.0 | 3.0 | GO:0035877 | death effector domain binding(GO:0035877) |
1.0 | 3.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
1.0 | 3.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.0 | 5.0 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
1.0 | 6.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.0 | 1.0 | GO:0051373 | FATZ binding(GO:0051373) |
1.0 | 2.9 | GO:0008142 | oxysterol binding(GO:0008142) |
1.0 | 2.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.0 | 5.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.0 | 3.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.9 | 1.9 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.9 | 4.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.9 | 4.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.9 | 2.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.9 | 2.7 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.9 | 3.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.9 | 10.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.9 | 6.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.9 | 1.7 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.8 | 10.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.8 | 2.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.8 | 4.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.8 | 5.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.8 | 3.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.8 | 7.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.8 | 4.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.8 | 1.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.8 | 2.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.8 | 3.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.8 | 3.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.8 | 2.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 2.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.8 | 17.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.8 | 3.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.8 | 8.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 3.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.7 | 4.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.7 | 7.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 3.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 4.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.7 | 2.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 2.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.7 | 0.7 | GO:0043398 | HLH domain binding(GO:0043398) |
0.7 | 4.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.7 | 14.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.7 | 1.4 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.7 | 3.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.7 | 1.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.7 | 11.3 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.7 | 2.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 5.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.6 | 2.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 1.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.6 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 4.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 1.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.6 | 2.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.6 | 5.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.6 | 5.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.6 | 6.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 2.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 20.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.6 | 4.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 7.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 0.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.6 | 17.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 1.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.6 | 2.8 | GO:0043559 | insulin binding(GO:0043559) |
0.6 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 3.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 4.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.5 | 5.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.5 | 9.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 1.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 2.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 10.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.5 | 2.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.5 | 4.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 3.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 3.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 4.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 5.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 8.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 1.5 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.5 | 12.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.5 | 2.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.5 | 1.5 | GO:0038100 | nodal binding(GO:0038100) |
0.5 | 1.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.5 | 2.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.5 | 1.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 2.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 6.2 | GO:0016208 | AMP binding(GO:0016208) |
0.5 | 0.5 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.5 | 16.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.5 | 0.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.5 | 3.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.5 | 0.5 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.5 | 1.4 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 5.4 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 1.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 2.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 2.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 1.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 3.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 1.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 2.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.4 | 2.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 2.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 3.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 0.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 1.7 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 1.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 1.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 2.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 3.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 1.2 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 1.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 1.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 8.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 2.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 1.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 0.4 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.4 | 6.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 3.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 7.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.4 | 2.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 1.6 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 1.9 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 1.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.4 | 1.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 1.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 6.8 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.4 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 2.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 1.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 1.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 1.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.4 | 2.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 0.4 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.4 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 0.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 6.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.4 | 1.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.4 | 1.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 1.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 4.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 1.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 1.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 22.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 3.9 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 5.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 1.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 1.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 2.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 2.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 1.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 1.0 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.3 | 3.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 1.0 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.3 | 4.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 11.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 4.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 2.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 0.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 0.9 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 2.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 2.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 0.6 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.3 | 0.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 2.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.3 | 2.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 0.9 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 1.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 5.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 6.0 | GO:0005537 | mannose binding(GO:0005537) |
0.3 | 1.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 0.8 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 1.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 0.3 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.3 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 7.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 1.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 1.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 0.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 1.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 1.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 2.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 3.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 2.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 0.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 0.8 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.3 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 0.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 1.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 3.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 0.8 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 1.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.3 | 2.6 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.3 | 2.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 1.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 3.8 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.3 | 4.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 0.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 1.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.3 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 0.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 4.5 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 2.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.2 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.2 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 1.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 2.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 1.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 1.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 1.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 1.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 1.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 1.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 3.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.7 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 1.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 1.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 1.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 1.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 2.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 0.8 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 1.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 1.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 1.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 1.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 1.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 1.4 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 4.9 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 1.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.2 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.2 | 1.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 1.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 1.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 1.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 17.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 3.7 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.2 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 9.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 1.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 3.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 2.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.7 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 1.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 1.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 3.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 0.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 1.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 1.4 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.2 | 1.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 1.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 1.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 1.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 7.5 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.2 | 28.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 2.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.5 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 1.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.6 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 1.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 1.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 1.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 1.8 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 0.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.9 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 1.3 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 7.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.2 | GO:0045703 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.1 | 2.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.6 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 2.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 1.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 1.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 6.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.4 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 8.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 1.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 14.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.7 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.1 | 0.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.5 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 3.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 29.8 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 2.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 1.1 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 1.8 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.7 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 1.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 6.9 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 1.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 3.8 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 1.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 1.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 1.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 1.7 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 4.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 1.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.1 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 2.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 1.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 4.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 2.6 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.4 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 1.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 3.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.3 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.5 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.1 | 2.4 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.9 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 3.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 1.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 6.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.4 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 5.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.3 | GO:0015645 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) fatty acid ligase activity(GO:0015645) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.2 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 2.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 2.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.1 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.8 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 1.3 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
0.1 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 1.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 1.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 2.1 | GO:0018733 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.1 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.8 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 7.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 1.3 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 1.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.5 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 1.9 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 5.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 1.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 5.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.4 | GO:0016894 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 1.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.1 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 4.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 1.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.2 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) aspartate oxidase activity(GO:0015922) |
0.0 | 6.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 6.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.6 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 1.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.6 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 3.1 | GO:0008194 | UDP-glycosyltransferase activity(GO:0008194) |
0.0 | 1.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.6 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.1 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.4 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 14.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 37.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.8 | 29.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.7 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 6.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.6 | 25.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.6 | 13.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.6 | 5.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.5 | 13.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 9.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 3.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 1.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 16.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 3.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 3.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 3.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 18.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 3.8 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 3.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 1.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 15.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 18.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 6.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 6.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 2.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 1.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 5.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 0.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 11.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 2.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 14.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 9.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 2.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 1.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 3.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 3.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 3.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 4.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 6.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 3.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 2.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 4.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 4.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 1.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 1.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 1.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 5.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 2.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 4.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 3.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 2.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 1.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 3.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 6.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 10.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 3.8 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 2.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 2.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 6.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 2.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.2 | 2.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 4.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 3.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 4.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 2.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 6.9 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 2.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 7.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 2.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 1.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 1.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 1.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 1.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 1.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 2.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 3.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 2.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 5.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 7.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.3 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 13.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 14.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.0 | 14.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.9 | 25.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 2.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.8 | 10.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.8 | 13.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.8 | 2.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.7 | 8.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 2.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.7 | 13.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.7 | 5.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 2.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.7 | 1.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.7 | 10.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.7 | 22.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.7 | 9.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 6.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 3.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.6 | 2.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 15.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 12.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.6 | 5.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.6 | 51.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 1.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 2.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.5 | 2.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 4.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 3.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 4.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 4.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 7.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 5.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.5 | 7.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.5 | 14.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 4.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 7.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 12.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.5 | 14.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 7.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 43.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 1.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 4.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 8.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 2.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 2.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 5.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 12.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.4 | 3.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 4.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 3.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 3.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 7.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 0.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 10.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 5.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 3.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 2.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 4.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 1.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 9.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 2.5 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 5.3 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.3 | 0.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 3.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 4.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 1.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.3 | 4.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 3.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 19.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 0.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 3.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 2.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 5.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 1.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 5.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 2.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 2.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 2.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 1.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 4.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 2.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 3.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 2.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 1.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 0.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 1.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 1.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 6.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 8.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 2.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 3.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 2.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 4.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 2.5 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 2.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 1.0 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.2 | 2.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 1.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 0.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 3.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 4.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 0.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 4.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 9.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 1.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.2 | 3.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 2.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 2.3 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.2 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 4.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 3.6 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.1 | 1.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 0.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 2.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 2.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 2.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 3.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.1 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 14.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 2.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 2.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.0 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 1.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 1.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 2.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 2.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 4.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.8 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.6 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 0.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 2.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 0.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |